江南化工(002226.SZ):鋒時互動完成工商註銷登記
格隆匯 3 月 26日丨江南化工(002226.SZ)公佈,公司於2016年5月18日召開的第四屆董事會第十四次會議審議通過了《關於投資天津鋒時互動科技有限公司暨關聯交易的議案》,同意公司以自有資金出資人民幣1,800萬元對天津鋒時互動科技有限公司(“鋒時互動”或“標的公司”)以現金方式增資,增資完成後公司持有鋒時互動註冊資本的10.00%。
近日,鋒時互動完成了工商註銷登記。此次清算並註銷的事項不構成關聯交易,也不構成重大資產重組。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.